These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18571901)

  • 1. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
    Goghari VM; Sponheim SR
    Schizophr Res; 2008 Aug; 103(1-3):186-91. PubMed ID: 18571901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.
    Silberschmidt AL; Sponheim SR
    Schizophr Res; 2008 Mar; 100(1-3):316-24. PubMed ID: 18201871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia.
    Docherty AR; Sponheim SR
    J Abnorm Psychol; 2008 Nov; 117(4):788-98. PubMed ID: 19025226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
    Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
    Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.
    McIntosh AM; Baig BJ; Hall J; Job D; Whalley HC; Lymer GK; Moorhead TW; Owens DG; Miller P; Porteous D; Lawrie SM; Johnstone EC
    Biol Psychiatry; 2007 May; 61(10):1127-34. PubMed ID: 17014827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism with auditory P300 in Chinese Han patients with schizophrenia.
    Kang C; Xu X; Liu H; Yang J
    Psychiatry Res; 2010 Dec; 180(2-3):153-5. PubMed ID: 20483173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder.
    Clelland CL; Drouet V; Rilett KC; Smeed JA; Nadrich RH; Rajparia A; Read LL; Clelland JD
    Transl Psychiatry; 2016 Sep; 6(9):e891. PubMed ID: 27622935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls.
    Wirgenes KV; Djurovic S; Sundet K; Agartz I; Mattingsdal M; Athanasiu L; Melle I; Andreassen OA
    Schizophr Res; 2010 Sep; 122(1-3):31-7. PubMed ID: 20605701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia.
    Bertolino A; Caforio G; Blasi G; Rampino A; Nardini M; Weinberger DR; Dallapiccola B; Sinibaldi L; Douzgou S
    Schizophr Res; 2007 Sep; 95(1-3):253-5. PubMed ID: 17644310
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles.
    Geller B; Cook EH
    Biol Psychiatry; 2000 Apr; 47(7):605-9. PubMed ID: 10745052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders.
    Carrà G; Nicolini G; Crocamo C; Lax A; Amidani F; Bartoli F; Castellano F; Chiorazzi A; Gamba G; Papagno C; Clerici M
    Nord J Psychiatry; 2017 Jul; 71(5):332-339. PubMed ID: 28635556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
    Tsai SJ; Hong CJ; Liao DL; Lai IC; Liou YJ
    Neuropsychobiology; 2004; 49(4):196-200. PubMed ID: 15118357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder.
    Lee SY; Chen SL; Wang YS; Chang YH; Huang SY; Tzeng NS; Lee IH; Yeh TL; Yang YK; Lu RB
    Behav Brain Res; 2013 Jan; 237():243-8. PubMed ID: 23026378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.
    Galderisi S; Maj M; Kirkpatrick B; Piccardi P; Mucci A; Invernizzi G; Rossi A; Pini S; Vita A; Cassano P; Stratta P; Severino G; Del Zompo M
    Neuropsychobiology; 2005; 52(2):83-9. PubMed ID: 16037677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
    Lee HY; Kim YK
    Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
    Kim YR; Kim JH; Kim SJ; Lee D; Min SK
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.